This page shows the latest Combination treatment news and features for those working in and with pharma, biotech and healthcare.
The results show that the Lynparza combination therapy significantly improved radiographic progression-free survival. ... the combination treatment was similar to that of earlier clinical trials.
The trial showed that adjuvant treatment using Verzenios in combination with endocrine therapy decreased the risk of breast cancer recurrence by 32%. ... The availability of the combination treatment on the NHS is supported by interim funding from the
The combination therapy is for patients with previously untreated diffuse large B-cell lymphoma. ... While many patients are initially responsive to treatment, four out of ten are not cured with the existing standard of care.
AstraZeneca’s (AZ) has announced that its treatment, Imfinzi (durvalumab), in combination with chemotherapy, has been accepted and given a Priority Review in the US for patients with locally advanced or ... There was a significant 25% reduction in the
The new, first-in-class fixed-dose dual immunotherapy combination treatment is administered as a single intravenous infusion. ... Opdualag is a new, first-in-class, fixed-dose, dual immunotherapy combination treatment and is administered as a single
It is the first antibody combination treatment authorised for use before exposure to COVID-19 infection in order to prevent disease licensed in the UK. ... AstraZeneca (AZ) has announced that its antibody combination treatment Evusheld (tixagevimab
More from news
Approximately 0 fully matching, plus 324 partially matching documents found.
A combination HIV treatment: AbbVie’s Kaletra. In an unprecedented move, AbbVie has suspended its patents on its combination HIV drug Kaletra, after it was identified as having potential against ... The combination drug was first included in Chinese
Another deal worth pondering about is the $265m exclusive license by AstraZeneca (AZ) of the approved Zurampic (lesuranid) plus a fixed dose combination with allopurinol for treatment of gout. ... 85 . Dong A (SK). Tobira (US). Cross license. Evogliptin
No deal terms were disclosed. The initial development plan will look at the combination therapy as a potential treatment for NHL. ... The treatment combines an antibody engineered to target CD19 with the cancer-killing agent maytansinoid.
The acquisition of Almirall's respiratory business enhances AZ's respiratory franchise bringing a portfolio of marketed and developmental single and combination products for the treatment of asthma and COPD. ... tremelimumab. Existing partners
And again, matching drugs that work well together will be crucial going forward: “Combination treatment will be a critical component; how best to put these drugs together with other checkpoint inhibitors, ... This includes people with NSCLC who have a
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
approval in combination with CyBorD for the treatment of newly diagnosed adult patients with AL amyloidosis. ... Prior to the approval of a new combination treatment for use across Europe, we conducted the first wave of our research to generate a
body. OncoSec has built a deep and diverse clinical pipeline utilizing TAVO as a potential treatment for multiple cancer indications either as a monotherapy or in combination with leading checkpoint inhibitors; ... Results from recently completed
The last few years have seen influential scientific advances, resulting in subtle shifts in how pharma tackles disease treatment. ... The treatment of aggressive diseases often benefits very noticeably from combination therapy, especially when involving
More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...